CBIO / Crescent Biopharma, Inc. - Implied Volatility - Fintel Labs

Crescent Biopharma, Inc.
US ˙ NasdaqCM ˙ US14888D2080

Implisitt volatilitet

Vi har ingen data for implisitt volatilitet for CBIO / Crescent Biopharma, Inc..

N/A

Dato IV30 IV90 HV20
Ingen data tilgjengelig
Dato IV30 IV90 HV20
Ingen data tilgjengelig
Dato IV30 IV90 HV20
Ingen data tilgjengelig
Volatilitetssmil
Et volatilitetssmil er en vanlig grafe som resulterer fra å plotte innløsningsprisen og implisitt volatilitet av en gruppe alternativer med samme underliggende ressurs og utløpsdato.
Other Listings
DE:C68
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Top Investors
Features
Explore
Help Center